L'Oréal has arrived to an agreement in the case of the patent of a cream antienvejecimiento. The three parts involved were a religious community, Carmel Laboratories, The University of Massachusets and the own French company.
At the beginning of March, the three parts involved communicated to the tribunar federal of Delaware that had arrived to an agreement to resolve his dispute and desestimar the case before 22 March.
Carmel Laboratories Is a subsidaria of Teresian Carmelites Inc, a religious community and a monastery with headquarters in Worcester, Massachusetts. The University of Massachusets and Carmel sued to 2017 to the group L'Oréal. The demand aimed to that the cream hidratante RevitaLift of L'Oréal and products of Maybelline, Lancôme and other marks of the French group infringían patents related with creams for the skin with the chemical adenosine. L'Oréal denied the indictments and convinced to the tribunar so that it invalidated the patents in 2021.
The specific details by which all the parts have arrived to the agreement have not been revealed by any of the three parts. However, sources of Reuters, aim to that representatives of L'Oréal boarded conversations with the technology patented with his creator James Dobson.